Sirolimus use in de "novo renal" transplantation

Nefrologia. 2006:26 Suppl 2:33-51.
[Article in English, Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use
  • Antilymphocyte Serum / administration & dosage
  • Antilymphocyte Serum / therapeutic use
  • Calcineurin Inhibitors
  • Child
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Double-Blind Method
  • Drug Interactions
  • Drug Therapy, Combination
  • Europe
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Diseases / chemically induced
  • Kidney Transplantation / immunology*
  • Multicenter Studies as Topic / statistics & numerical data
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Rats
  • Registries
  • Sirolimus / administration & dosage
  • Sirolimus / adverse effects
  • Sirolimus / therapeutic use*
  • Tacrolimus / administration & dosage
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use
  • United States

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Cyclosporine
  • thymoglobulin
  • Sirolimus
  • Tacrolimus